National Advertising Division Recommends Smarter Reviews, a Product Review Site, Discontinue or Modify its Rankings and Review Format

New York, NY – February 27, 2024 – Following a challenge brought by BBB National Programs’ National Advertising Division as part of its routine monitoring program, the National Advertising Division recommended that product review site, Smarter Reviews:

  • Discontinue its rankings and reviews format, or 
  • Modify its advertising to avoid conveying a message that the review and rankings webpages and the reviews and rankings themselves are unbiased, genuine, and independent and on an unbiased and objective review site.

 

In a Google search result, the claim, “2023’s Top Eye Treatment for Refreshed, Youthful-Looking Eyes: We reveal the top 5 products for reducing & preventing the look of aging skin around the eyes,” appeared as part of an article on Smarter-Reviews.com.

The National Advertising Division (NAD) inquiry focused on whether the challenged claims in both the Google Search result and the eye cream rankings on the Smarter-Reviews.com website reasonably conveyed that they were independent and objective, when, in fact, they are advertisements. 

During the inquiry, Smarter Reviews modified its webpage to add several disclosures that the webpage is advertising for TruAlchemy’s Eye Elixir, the #1 ranked product, including “owned and operated by Scale Media, Inc.”  

While NAD appreciated the changes made by Smarter Reviews, NAD determined that it was not sufficiently clear that the content is advertising, noting that the reviews and rankings on the webpage appear to be the product of a dispassionate, independent analysis conducted by an editorial team. 

NAD concluded that when advertisers control review websites, a disclosure, even if clear and conspicuous, may not be sufficient to alert consumers that the review is created or sponsored by the advertiser and advertising websites. Further, NAD found no evidence that Smarter Reviews has the expertise it purports to have in reviewing and ranking products, nor is there evidence that the endorsement is based on the expertise the website purports to have. 

In its advertiser statement, Smarter Reviews stated that it “agrees to comply with NAD’s recommendations” although it “believes that the content and the disclosures on Smarter Reviews clearly and conspicuously explain the nature of the relationship between the products advertised and Scale Media, consistent with the FTC’s Guides Concerning the Use of Endorsements and Testimonials in Advertising.”

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB procedures, this release shall not be used for advertising or promotional purposes.

Please Note: The advertising at issue in this case was initially referred to an appropriate government agency. Following the referral, Smarter Reviews subsequently returned to NAD and agreed to participate in the advertising self-regulatory forum.

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

National Advertising Division Recommends Dr. Luke Healthcare Discontinue Treatment Claims for its Fungal Nail Renewal Product

New York, NY – July 24, 2024 – The National Advertising Division recommended Dr. Luke Healthcare discontinue certain claims for Dr. Luke’s Fungal Nail Renewal product, including health-related claims, natural claims, and claims that a doctor recommends the product or that it treats a medical condition.

Read the Decision Summary
Decision

National Advertising Division Finds Flag Image on Kendamil Infant Formula Packaging Conveys Supported Message about Products’ Origin

New York, NY – July 17, 2024 – In a Fast-Track SWIFT challenge, the National Advertising Division determined that use of a flag image on product packaging for Kendal Nutricare’s Kendamil infant formula reasonably conveys a supported message about the products’ origin. 

Read the Decision Summary
Decision

In National Advertising Division Case, GuruNanda Voluntarily Discontinues Claims Made through Influencers for Coconut Pulling Oil Products

New York, NY – July 16, 2024 – The National Advertising Division has closed a Fast-Track SWIFT challenge regarding claims that GuruNanda’s coconut pulling oil products can “naturally reverse a cavity” and “reverse cavities.” 

Read the Decision Summary
Decision

National Advertising Division Refers Health-Related Advertising Claims for Prolacta’s Human Milk Fortifier to Regulatory Agencies

New York, NY – July 15, 2024 – The National Advertising Division will refer advertising claims made by Prolacta Bioscience for its Human Milk Fortifier to the Federal Trade Commission (FTC) and Food and Drug Administration (FDA) for review.

Read the Decision Summary